Most Read Articles
Pearl Toh, 4 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 20 Oct 2020
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Nocturia is a risk factor for mortality, according to the results of the Nagahama Study, which boasts of a low incidence of missing data and high representation of the general population.

VTE, bleeding risk unaffected by pregnancy in Klippel-Trenaunay syndrome

19 Nov 2019
It was speculated that the family’s wish for a second child in a short period of time might be the reason why they allegedly refused permission for a C-section delivery.

Pregnancy does not appear to aggravate the risk of bleeding and venous thromboembolism (VTE) in women with Klippel-Trenaunay syndrome (KTS), a recent study has shown.

Researchers retrospectively reviewed the medical records of 70 women with KTS who have had at least one pregnancy in the past; 185 pregnancies were included in the analysis. Outcomes included VTE, defined as deep vein thrombosis, pulmonary embolism or both, and significant bleeding events. A parallel group of 64 nulligravid comparators was also included.

Fourteen women who have had pregnancies experienced VTE episodes, yielding an overall lifetime prevalence rate of 20.0 percent. This included seven cases during pregnancy, four in the postpartum period and seven during other points in their lifetime.

In comparison, there were 16 VTE cases in the nulligravid group, resulting in a prevalence rate of 25.0 percent. This was not significantly different than in those with previous pregnancies (p=0.93).

On the other hand, significant bleeding occurred in six women in the pregnancy group, corresponding to a prevalence rate of 8.6 percent. Four of these events occurred during pregnancy or during postpartum. Two pregnancies were complicated by postpartum haemorrhage, while one woman experienced both VTE and significant bleeding associated with pregnancy.

Six nulligravid women developed significant bleeding events, with a prevalence rate of 9.4 percent. This was statistically similar to the pregnancy group (p=0.54).

In the nulligravid group, one patient death occurred secondary to VTE. There were no such reports in patients who had a prior pregnancy.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 4 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 20 Oct 2020
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Nocturia is a risk factor for mortality, according to the results of the Nagahama Study, which boasts of a low incidence of missing data and high representation of the general population.